Search Results 831-840 of 17124 for monoclonal antibody

1. Immune globulin and hyaluronidase (subcutaneous route) - Side effects & dosage - Mayo Clinic

   Immune globulin and recombinant human hyaluronidase injection contains antibodies that make your immune system stronger. It is used for patients who have ...

2. Safety and Efficacy of SA4Ag Vaccine in Adults Having Elective Open Posterior Spinal Fusion Procedures With Multilevel Instrumentation - Mayo Clinic

   ... monoclonal antibodies) prior to the index hospital admission. Previous administration of S aureus vaccine or S aureus/Candida vaccine. Antibiotic therapy ...

3. Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) - Mayo Clinic

   Prior anti-cancer monoclonal antibody (mAb) within 4 weeks prior to study Day 1 or not recovered from an adverse event caused by mAbs administered more than 4 ...

4. A Study of SC‑004 in Subjects With Advanced Solid Tumors - Mayo Clinic

   Chemotherapy, small molecule inhibitors, radiation, and/or other investigational anticancer agents (excluding investigational monoclonal antibodies): within 2 ...

5. Evaluation of CRS-207 With Pembrolizumab in Previously Treated MPM - Mayo Clinic

   Active secondary malignancy; Prior anti-cancer monoclonal antibody within 4 weeks prior to first dose of study drug, or not recovered from adverse effects ...

6. A Study to Assess the Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma Receiving Oral ABBV-453 Tablets - Mayo Clinic

   therapy, including a proteasome inhibitors (PI), an Immunomodulatory drugs (IMID), and an anti-CD38 monoclonal antibody. - Permitted to be venetoclax or BCL ...

7. Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ANX005 in Subjects With Warm Autoimmune Hemolytic Anemia (wAIHA) - Mayo Clinic

   - History of splenectomy within the 3 months prior to screening. - Received rituximab or other anti-CD20 monoclonal antibody <3 months prior to screening ...

8. Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma With Excess Glucocorticoid Production - Mayo Clinic

   - History of severe hypersensitivity to another monoclonal antibody - Other concurrent cancer or a history of another invasive malignancy within the last 3

9. A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis - Mayo Clinic

   A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to ...

10. Pemigatinib to Treat Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations - Mayo Clinic

    ... monoclonal antibody, if eligible for this therapy;. Anti-EGFR (epidermal growth factor receptor) monoclonal antibody, if eligible for this therapy.